TARO 16
Pill imprint TARO 16 has been identified as Carbamazepine 100 mg.
Carbamazepine is used in the treatment of peripheral neuropathy; epilepsy; trigeminal neuralgia; bipolar disorder; schizoaffective disorder (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy.
Carbamazepine 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Carbamazepine Images
- Imprint:
-
TARO 16
- Strength:
- 100 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Dibenzazepine anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Taro Pharmaceuticals U.S.A., Inc.
- National Drug Code (NDC):
- 51672-4041
| NDC Code | Manufacturer / Repackager |
|---|---|
| 62584-0639 | Amerisource Health Services |
| 58016-0501 | Southwood Pharmaceuticals Inc (repackager) |
| 49999-0782 | Lake Erie Medical and Surgical Supply (repackager) |
| 54569-2795 | A S Medication Solutions LLC (repackager) |
Note: Inactive ingredients may vary.
More Carbamazepine resources
- Carbamazepine
- Carbamazepine (Wolters Kluwer)
- Carbamazepine Chewable Tablets (Wolters Kluwer)
- Carbamazepine Suspension (Wolters Kluwer)
- Carbamazepine Sustained-Release Capsules (Wolters Kluwer)
- Carbamazepine Sustained-Release Tablets (Wolters Kluwer)
- carbamazepine (Cerner Multum)
- carbamazepine (Micromedex) - Includes Dosage Information
- Carbamazepine (AHFS DI)
- Carbamazepine (FDA)
- Carbamazepine Capsules (FDA)
- Carbamazepine Chewable (FDA)
- Carbamazepine ER (FDA)
- Carbamazepine Oral Suspension (FDA)
- Carbamazepine (Wolters Kluwer)


